Intermex Reports First-Quarter Results
GlobeNewswire· 2025-05-07 12:00
Company reports solid volume growth, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- International Money Express, Inc. (NASDAQ: IMXI) ("Intermex" or the "Company"), one of the nation's leading global omnichannel money transfer services to Latin America and the Caribbean, today reported financial and operating results for the first quarter of 2025. Financial performance highlights for the first quarter of 2025: Bob Lisy, C ...
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
GlobeNewswire· 2025-05-07 12:00
FOR MORE INFORMATION, PLEASE CONTACT: Investors: John J Kirby Interim Chief Financial Officer jkirby@verrica.com Kevin Gardner LifeSci Advisors kgardner@lifesciadvisors.com Individuals may participate in the live call via telephone by dialing 1-800-343-4136 (domestic) or 1-203-518- 9843 (international) and using the conference ID: VERRICA. Participants are asked to dial in 10 minutes before the start of the call to register. A live audio webcast of the call be accessed by visiting the investor relations sec ...
GoHealth’s Statement on Recent Allegations in the United States False Claims Act Complaint
GlobeNewswire· 2025-05-07 12:00
GoHealth firmly denies allegations; affirms leadership in regulatory compliance and prioritization of beneficiaries' needs CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, firmly denies the allegations made by the Government in a lawsuit in which the company has been named as a defendant related to events that allegedly occurred between 2016 and 2021. We are disappointed that the Government ...
Enphase Energy Launches IQ Balcony Solar System in Germany
GlobeNewswire· 2025-05-07 12:00
"Germany's energy landscape is changing, and products like the Enphase IQ Balcony Solar System are making the shift easier and more accessible," said Kevin Malek, CEO of solago, a bundler of solar energy products in Germany. "This system empowers people to generate their own clean energy – even without a traditional roof – while enjoying the safety, reliability, and simplicity that Enphase is known for." FREMONT, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy t ...
Aqua Metals Announces CFO Transition and Appointment of Eric West
GlobeNewswire· 2025-05-07 12:00
RENO, Nev., May 07, 2025 (GLOBE NEWSWIRE) -- Aqua Metals (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling, today announced a leadership transition in the role of Chief Financial Officer. Judd Merrill, who has served as CFO since 2018, is now taking a role as CFO of a publicly listed company with increasing responsibilities and will begin transitioning from his position effective May 16, 2025. To support a smooth transition and continued momentum, Judd will actively support the Company as a ...
Advent Technologies Announces Bryan Holasek as Chief Strategy Officer
GlobeNewswire· 2025-05-07 12:00
Cautionary Note Regarding Forward-Looking Statements Mr. Holasek has over 42 years of experience in advancing technology from concept to product development. He was introduced to HT-PEM Fuel Cells through Trenergi Corp. He has founded several tech companies, including Revolutionary Integrations Group (AI and Machine Learning) and 369 Power and Energy Group (alternative energy systems). Previously, Mr. Holasek was Vice President of Corporate Development & Strategy at FDE Hydro and held roles such as Chief En ...
NKGen Biotech to Present Troculeucel Clinical and Biomarker Results at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire· 2025-05-07 12:00
SANTA ANA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced an upcoming presentation on Phase 1 clinical data from the Company's Phase 1/2a trial evaluating troculeucel, cryopreserved expanded autologous NK cell therapy, in patients with moderate Alzheimer's disease (AD), at ...
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire· 2025-05-07 12:00
RADNOR, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that management will be participating in the Bank of America Securities 2025 Health Care Conference being held in Las Vegas on May 12-15, 2025. Bank of America Securities Health Care Conferen ...
LGI Homes is Now Selling at Creekside Estates Near Dallas
GlobeNewswire· 2025-05-07 12:00
The Cypress Plan by LGI Homes at Creekside Estates features four bedrooms, two-and-a-half bathrooms, and an expansive living area. TERRELL, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce that sales have commenced in Creekside Estates in Terrell, Texas. LGI Homes is building 141 lots in this charming community in Kaufman County, offering homebuyers a perfect combination of small-town living, vibrant local attractions and easy access to Dallas. Creekside Estates ...
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire· 2025-05-07 12:00
Recent Highlights and Anticipated Milestones: Bitopertin: GlyT1 Inhibitor (Heme Synthesis Modulator) DISC-0974: Anti-Hemojuvelin Antibody (Hepcidin Suppression) Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025 Expect data readouts for DISC-0974 program in H2 2025, including init ...